Hemodynamic Right Heart Catheterization Before Transcatheter Mitral and Tricuspid Therapies.

IF 8.4 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Circulation: Heart Failure Pub Date : 2025-05-22 DOI:10.1161/CIRCHEARTFAILURE.124.012489

Cosmo Godino, Antonio Sisinni, Luca Raone, Francesco Maria Sparasci, Andrea Munafò, Alberto Margonato, Luca Testa, Maurizio Taramasso, Fabien Praz, Sami Alnasser, Neil Fam, Rodrigo Estevez-Loureiro, Francesco Saia, Francesco Bedogni, Azeem Latib, Claudia Baratto, Francesca Coppi, Marianna Adamo, Altin Palloshi, Gabriele Crimi, Scott Lim, Francesco Maisano, Ryan J Tedford, Sergio Caravita

引用次数: 0

Abstract

Recent findings emphasize the potential role of invasive hemodynamic assessment in guiding transcatheter mitral and tricuspid valve percutaneous interventions. Right heart catheterization-derived parameters offer insights into hemodynamic changes associated with valvular heart diseases, pulmonary hypertension phenotyping, and right ventricular to pulmonary artery coupling. This might improve prognostic stratification for candidates to transcatheter therapies. This review provides a clinical overview of available data regarding the utility of preoperative right heart catheterization-derived parameters in patients undergoing mitral and tricuspid percutaneous repair or replacement.

查看原文本刊更多论文

经导管二尖瓣和三尖瓣治疗前的右心导管血流动力学。

最近的研究结果强调了有创血流动力学评估在指导经导管二尖瓣和三尖瓣经皮介入治疗中的潜在作用。右心导管衍生参数提供了与瓣膜性心脏病、肺动脉高压表型和右心室-肺动脉耦合相关的血流动力学变化的见解。这可能会改善经导管治疗候选者的预后分层。这篇综述提供了关于术前右心导管衍生参数在接受二尖瓣和三尖瓣经皮修复或置换术的患者中的应用的现有数据的临床概述。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Circulation: Heart Failure 医学-心血管系统

CiteScore

12.90

自引率

3.10%

发文量

271

审稿时长

6-12 weeks

期刊介绍： Circulation: Heart Failure focuses on content related to heart failure, mechanical circulatory support, and heart transplant science and medicine. It considers studies conducted in humans or analyses of human data, as well as preclinical studies with direct clinical correlation or relevance. While primarily a clinical journal, it may publish novel basic and preclinical studies that significantly advance the field of heart failure.